article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Pfizer (New York, New York) has announced that it will not begin any new clinical trials in Russia and will halt recruitment in trials that are underway in Russia. Thermo Fisher states on its website that “Given the ongoing conflict, we have paused sales and manufacturing operations in Russia and Belarus.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

Manufacturing agreements for infectious diseases. Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Large Brazilian pharma companies already play a major role in distributing Covid-19 vaccines to all of Latin America.